• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Sidoti Events, LLC's Virtual August Micro-Cap Conference

    8/13/24 9:30:00 AM ET
    $BYRN
    $CIA
    $COOT
    $DTIL
    Industrial Machinery/Components
    Miscellaneous
    Life Insurance
    Finance
    Get the next $BYRN alert in real time by email

    NEW YORK, NY / ACCESSWIRE / August 13, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 14-15, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.

    Presentation Schedule

    *All Times EDT

    Wednesday, August 14, 2024 (Day 1)

    8:30-9:00

    *****

    Alta Global Group (MMA)

    Mobile-health Network (MNDR)

    9:15-9:45

    Steakholder Foods Ltd. (STKH)

    *****

    Regenx Tech (RGXTF)

    10:00-10:30

    *****

    Genius Group (GNS)

    *****

    10:45-11:15

    ARC Document Solutions (ARC)

    Xtract One Technologies (XTRA.TO)

    Citius Pharmaceuticals, Inc. (CTXR)

    11:30-12:00

    AstroNova, Inc. (ALOT)

    L.B. Foster (FSTR)

    KindlyMD (KDLY)

    12:15-12:45

    Serve Robotics (SERV)

    Orion Energy Systems, Inc. (OESX)

    *****

    1:00-1:30

    Brightcove, Inc. (BCOV)

    United States Antimony Corp (UAMY)

    Oncocyte (OCX)

    1:45-2:15

    *****

    Kingstone Companies, Inc (KINS)

    Inspire Veterinary Partners (IVP)

    2:30-3:00

    Intrusion Inc (INTZ)

    eHealth (EHTH)

    Virpax Pharmaceuticals (VRPX)

    3:15-3:45

    a.k.a. Brands (AKA)

    ReconAfrica (RECO | RECAF)

    Cibus (CBUS)

    4:00-4:30

    Paysign, Inc. (PAYS)

    Brilliant Earth Group, Inc. (BRLT)

    Atara Bio (ATRA)

    1x1s Only

    (14th)

    Mayville Engineering Co. (MEC)

    Bassett Furniture (BSET)

    Kelly Services, Inc. (KELYA)

    Sonendo (SONX)

    Trinity Biotech (TRIB)

    *****

    *All Times EDT

    Thursday, August 15, 2024 (Day 2)

    8:30-9:00

    *****

    Australian Oilseeds Holdings Ltd. (COOT)

    Genprex, Inc. (GNPX)

    9:15-9:45

    *****

    Mistras Group (MG)

    Kamada Ltd (KMDA)

    10:00-10:30

    Urgent.ly Inc. (ULY)

    Ranger Energy Services (RNGR)

    Precision BioSciences (DTIL)

    10:45-11:15

    Byrna Technologies (BYRN)

    Smart Sand, Inc. (SND)

    Gyre Therapeutics Inc. (GYRE)

    11:30-12:00

    Synchronoss Technologies (SNCR)

    Citizens, Inc. (CIA)

    Anika Therapeutics (ANIK)

    12:15-12:45

    *****

    Riley Exploration Permian (REPX)

    Aytu BioPharma (AYTU)

    1:00-1:30

    Sky Harbour Group Corp. (SKYH)

    Lee Enterprises (LEE)

    T2 Biosystems, Inc (TTOO)

    1:45-2:15

    *****

    OppFi Inc. (OPFI)

    Alpha Teknova Inc. (TKNO)

    2:30-3:00

    *****

    Beneficient (BENF)

    Cadrenal Therapeutics (CVKD)

    1x1s Only

    (15th)

    Matthews International (MATW)

    Mayville Engineering Co. (MEC)

    Sonendo (SONX)

    Trinity Biotech (TRIB)

    *****

    *****

    About Sidoti Events, LLC ("Events") and Sidoti & Company, LLC ("Sidoti")
    In 2023, Sidoti & Company, LLC (www.sidoti.com) formed an affiliate company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the 25 years of experience Sidoti has as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises approximately 150 equities of which greater than 60 percent participate in the firm's rapidly growing Company Sponsored Research ("CSR") program. In 2024, Sidoti established Lighthouse Equity Research as an extension of its CSR program to meet the specific needs of companies not valued using traditional metrics or that face challenges obtaining coverage due to political risks or other factors. Events is a leading provider of corporate access through the eight investor conferences it hosts each year. By virtue of its direct ties to Sidoti, Event's benefits from Sidoti's small- and microcap-focused nationwide sales force, which has connections with 2,500 institutional relationships in North America. This enables Events to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

    SOURCE: Sidoti & Company, LLC



    View the original press release on accesswire.com

    Get the next $BYRN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BYRN
    $CIA
    $COOT
    $DTIL

    CompanyDatePrice TargetRatingAnalyst
    Urgent.ly Inc.
    $ULY
    7/1/2025$15.00Neutral
    Chardan Capital Markets
    Kamada Ltd.
    $KMDA
    3/21/2025$15.00Buy
    The Benchmark Company
    Gyre Therapeutics Inc.
    $GYRE
    3/11/2025Outperform
    Noble Capital Markets
    Precision BioSciences Inc.
    $DTIL
    1/10/2025$34.00Market Perform → Outperform
    BMO Capital Markets
    Synchronoss Technologies Inc.
    $SNCR
    11/25/2024$11.00 → $13.00Neutral → Buy
    ROTH MKM
    Byrna Technologies Inc.
    $BYRN
    8/28/2024$14.00Buy
    ROTH MKM
    Kamada Ltd.
    $KMDA
    7/3/2024$18.00Buy
    Stifel
    Precision BioSciences Inc.
    $DTIL
    4/30/2024$19.00Buy
    Guggenheim
    More analyst ratings

    $BYRN
    $CIA
    $COOT
    $DTIL
    SEC Filings

    See more
    • SEC Form S-3 filed by Urgent.ly Inc.

      S-3 - Urgent.ly Inc. (0001603652) (Filer)

      7/3/25 4:48:00 PM ET
      $ULY
      EDP Services
      Technology
    • SEC Form S-3 filed by Urgent.ly Inc.

      S-3 - Urgent.ly Inc. (0001603652) (Filer)

      7/3/25 4:47:38 PM ET
      $ULY
      EDP Services
      Technology
    • SEC Form PRE 14A filed by Genprex Inc.

      PRE 14A - Genprex, Inc. (0001595248) (Filer)

      7/3/25 4:46:13 PM ET
      $GNPX
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BYRN
    $CIA
    $COOT
    $DTIL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Brown Melinda bought $6,963 worth of shares (1,682 units at $4.14), increasing direct ownership by 9% to 20,565 units (SEC Form 4)

      4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)

      6/27/25 6:14:40 AM ET
      $DTIL
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Director Buehler Kevin bought $21,116 worth of shares (5,076 units at $4.16), increasing direct ownership by 22% to 28,137 units (SEC Form 4)

      4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)

      6/27/25 6:14:20 AM ET
      $DTIL
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • President & CEO Stenberg Jon bought $66,407 worth of Citizens (19,914 units at $3.33), increasing direct ownership by 11% to 198,930 units (SEC Form 4)

      4 - CITIZENS, INC. (0000024090) (Issuer)

      6/18/25 2:42:21 PM ET
      $CIA
      Life Insurance
      Finance

    $BYRN
    $CIA
    $COOT
    $DTIL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • KellyOCG + Sevenstep Named RPO Leader, Star Performer by Everest Group

      TROY, Mich., July 02, 2025 (GLOBE NEWSWIRE) -- KellyOCG® + Sevenstep, the permanent hiring solutions business of leading specialty talent solutions provider Kelly (NASDAQ:KELYA, KELYB)), has been named a Leader and Star Performer on Everest Group's 2025 Recruitment Process Outsourcing (RPO) Services PEAK Matrix® Assessment – Global. The recognition comes just months after the formal integration of KellyOCG's RPO specialty and Motion Recruitment Partners' talent acquisition brand, Sevenstep. Everest Group's PEAK Matrix® provides an objective, data-driven assessment of global RPO providers based on their market impact, vision and capability. Providers are assessed in seven categories: marke

      7/2/25 8:30:00 AM ET
      $KELYA
      $KELYB
      Professional Services
      Consumer Discretionary
    • Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround

      -Trinity Biotech projects it reached Adjusted EBITDA1 -positive operations during Q2 2025 and expects to be Adjusted EBITDA1 positive going forward, reflecting continued strong execution on its comprehensive transformation plan.- - The Company now expects to be meaningfully Adjusted EBITDA1 -positive and cashflow positive from ongoing operating activities, starting Q3 2025 and into the foreseeable future.- DUBLIN, July 01, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today provided a business update announcing that the Company believes

      7/1/25 9:00:01 AM ET
      $TRIB
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • Synchronoss Joins Russell 2000 Index, Solidifying Position as a Leading Small-Cap SaaS Company

      BRIDGEWATER, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies, Inc. ("Synchronoss") (NASDAQ:SNCR), a global leader and innovator in personal cloud platforms, today announced that the company has joined the Russell 2000® Index, effective upon the U.S. market open on June 30, 2025. Prior to its inclusion in the Russell 2000 Index, Synchronoss had completed a strategic transformation to become a leading global cloud solutions provider, resulting in a more predictable, stable business model while delivering improved profitability. In the first quarter of 2025, the Company continued to deliver strong financial performance consistent with results seen throughout 2024. "We'r

      7/1/25 8:00:00 AM ET
      $SNCR
      EDP Services
      Technology

    $BYRN
    $CIA
    $COOT
    $DTIL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Chardan Capital Markets initiated coverage on Urgently with a new price target

      Chardan Capital Markets initiated coverage of Urgently with a rating of Neutral and set a new price target of $15.00

      7/1/25 7:54:12 AM ET
      $ULY
      EDP Services
      Technology
    • The Benchmark Company initiated coverage on Kamada with a new price target

      The Benchmark Company initiated coverage of Kamada with a rating of Buy and set a new price target of $15.00

      3/21/25 8:11:15 AM ET
      $KMDA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Noble Capital Markets initiated coverage on Gyre Therapeutics

      Noble Capital Markets initiated coverage of Gyre Therapeutics with a rating of Outperform

      3/11/25 10:02:24 AM ET
      $GYRE
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BYRN
    $CIA
    $COOT
    $DTIL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Medical Officer Berger Mark Stanley covered exercise/tax liability with 4,500 shares, decreasing direct ownership by 20% to 17,971 units (SEC Form 4)

      4 - Genprex, Inc. (0001595248) (Issuer)

      7/1/25 5:52:13 PM ET
      $GNPX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • President, CEO and CFO Confer Ryan M. covered exercise/tax liability with 5,775 shares, decreasing direct ownership by 15% to 32,968 units (SEC Form 4)

      4 - Genprex, Inc. (0001595248) (Issuer)

      7/1/25 5:51:04 PM ET
      $GNPX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Financial Officer Kearnes Laurilee covered exercise/tax liability with 1,426 shares and converted options into 5,000 shares, increasing direct ownership by 102% to 7,074 units (SEC Form 4)

      4 - Byrna Technologies Inc. (0001354866) (Issuer)

      6/30/25 6:45:31 AM ET
      $BYRN
      Industrial Machinery/Components
      Miscellaneous

    $BYRN
    $CIA
    $COOT
    $DTIL
    Leadership Updates

    Live Leadership Updates

    See more
    • Ranger Energy Services, Inc. Announces Dual Listing on NYSE Texas

      Ranger Energy Services, Inc. (NYSE:RNGR) (the "Company") announced today the dual listing of its common stock on NYSE Texas, the newly launched, fully electronic equities exchange headquartered in Dallas, TX. The Company will maintain its primary listing on the New York Stock Exchange (the "NYSE") and will trade under the same ticker symbol, "RNGR," on NYSE Texas. Ranger CEO Stuart Bodden commented, "We are excited to join the NYSE Texas as a Founding Member. Ranger has always maintained a deep presence here in the state, employing over a thousand Texans from the Permian Basin to our Houston headquarters and everywhere in between. We look forward to continuing to Lead the Way as a champio

      6/26/25 4:10:00 PM ET
      $RNGR
      Oilfield Services/Equipment
      Energy
    • Urgently Promotes Michael Port to Chief Financial Officer

      VIENNA, Va., May 27, 2025 (GLOBE NEWSWIRE) -- Urgent.ly Inc. (NASDAQ:ULY) ("Urgently"), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today announced the appointment of Michael Port as Chief Financial Officer, effective June 6, 2025. Mr. Port assumes the role from Timothy C. Huffmyer, who is stepping down as Chief Financial Officer to pursue other opportunities. Mr. Port previously served as Senior Vice President of Finance of Urgently. Prior to joining Urgently, Mr. Port served as Vice President of Finance and Controller of Lordstown Motors Corp. ("Lordstown"), an electric vehicle original equipment manufacturer and innovator, from Sep

      5/27/25 7:30:18 AM ET
      $ULY
      EDP Services
      Technology
    • AEye Appoints Doron Simon to its Board of Directors

      AEye, Inc. (NASDAQ:LIDR), a global leader in adaptive, high-performance lidar solutions, announced it has appointed Doron Simon to its Board of Directors effective April 29, 2025. Mr. Simon's appointment is the result of the Company's commitment to the thoughtful and continuous refreshment of its Board to best meet the evolving needs of AEye. Mr. Simon, age 59, brings deep experience in strategic consulting and M&A advisory services as the Founder of DSimonSays Inc., Managing Director at Stanton Park Capital, and a Partner at Transformation Equity Partners. His advisory work focuses on scaling technology firms to profitability through organic and non-organic growth. Prior to being an advis

      5/1/25 7:00:00 PM ET
      $LIDR
      $NICE
      $TSEM
      $ULY
      Auto Parts:O.E.M.
      Consumer Discretionary
      Computer Software: Prepackaged Software
      Technology

    $BYRN
    $CIA
    $COOT
    $DTIL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Ranger Energy Services Inc.

      SC 13D/A - Ranger Energy Services, Inc. (0001699039) (Subject)

      12/12/24 6:49:54 PM ET
      $RNGR
      Oilfield Services/Equipment
      Energy
    • Amendment: SEC Form SC 13G/A filed by Synchronoss Technologies Inc.

      SC 13G/A - SYNCHRONOSS TECHNOLOGIES INC (0001131554) (Subject)

      12/6/24 4:40:16 PM ET
      $SNCR
      EDP Services
      Technology
    • Amendment: SEC Form SC 13D/A filed by Ranger Energy Services Inc.

      SC 13D/A - Ranger Energy Services, Inc. (0001699039) (Subject)

      12/4/24 8:57:26 PM ET
      $RNGR
      Oilfield Services/Equipment
      Energy

    $BYRN
    $CIA
    $COOT
    $DTIL
    Financials

    Live finance-specific insights

    See more
    • Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation

      Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to Outsourced Production Reduces Fixed Costs and Supports Trinity's Broader Profitability and Growth Objectives DUBLIN, June 24, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced it has received World Health Organization (WHO) approval for the offshored and outsourced upstream manufacturing activities of its high-volume TrinScreen™ HIV rapid test, a cornerstone diagnostic product used in HI

      6/24/25 8:00:38 AM ET
      $TRIB
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • Byrna Technologies to Report Fiscal Second Quarter 2025 Financial Results on Thursday, July 10, 2025 at 9:00 a.m. ET

      ANDOVER, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. ("Byrna" or the "Company") (NASDAQ:BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, will hold a conference call on Thursday, July 10, 2025 at 9:00 a.m. Eastern time to discuss its financial results for the fiscal second quarter ended May 31, 2025. Financial results will be issued in a press release prior to the call. Byrna management will host the presentation, followed by a question-and-answer period. Date: Thursday, July 10, 2025Time: 9:00 a.m. Eastern timeToll-Free Dial-In: 877-709-8150International Dial

      6/24/25 8:00:00 AM ET
      $BYRN
      Industrial Machinery/Components
      Miscellaneous
    • Byrna Technologies Announces Preliminary Fiscal Second Quarter Record Revenues of $28.5 Million

      ANDOVER, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. ("Byrna" or the "Company") (NASDAQ:BYRN), a technology company, specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, today announced select preliminary financial results for the fiscal second quarter ended May 31, 2025. Preliminary Second Quarter ResultsBased on preliminary unaudited results, Byrna expects total revenue for the fiscal second quarter of 2025 to be $28.5 million, representing a 41% increase from $20.3 million in the fiscal second quarter of 2024. The record Q2 performance was driven by strong early demand for the new Byrna Compact Launcher (CL

      6/5/25 4:05:00 PM ET
      $BYRN
      Industrial Machinery/Components
      Miscellaneous